A recent study published in JAMA Network Open examined the true incidence of Long COVID, where individuals experience symptoms for over three months after COVID-19 infection. By comparing COVID-19 survivors with non-infected individuals, the study aimed to accurately measure the prevalence of Long COVID. Researchers looked for anti-nucleocapsid (anti-N) antibodies, distinguishing natural infection from vaccination. The findings provide valuable insights into the long-term health impacts of COVID-19, addressing challenges in tracking slow-onset health issues post-infection. This research contributes to understanding the broader implications of the pandemic beyond immediate health outcomes.
New Research Sheds Light on COVID-19 Long-Term Effects
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/04/14153900/IMG_IMG_iStock-133238207_2_1_N3B7JM3G-860x484.jpg)